Canada
· Delayed Price · Currency is CAD ZYUS Life Sciences Statistics
Total Valuation
TSXV:ZYUS has a market cap or net worth of CAD 59.62 million. The enterprise value is 71.37 million.
| Market Cap | 59.62M |
| Enterprise Value | 71.37M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:ZYUS has 76.44 million shares outstanding. The number of shares has increased by 28.41% in one year.
| Current Share Class | 76.44M |
| Shares Outstanding | 76.44M |
| Shares Change (YoY) | +28.41% |
| Shares Change (QoQ) | +3.04% |
| Owned by Insiders (%) | 52.15% |
| Owned by Institutions (%) | 0.20% |
| Float | 34.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 123.96 |
| PB Ratio | -7.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.07 |
| EV / Sales | 148.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.29 |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.27 |
| Interest Coverage | -15.63 |
Financial Efficiency
Return on equity (ROE) is -546.27% and return on invested capital (ROIC) is -57.48%.
| Return on Equity (ROE) | -546.27% |
| Return on Assets (ROA) | -39.54% |
| Return on Invested Capital (ROIC) | -57.48% |
| Return on Capital Employed (ROCE) | -12,530.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.70% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -29.70% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.82 |
| Relative Strength Index (RSI) | 60.34 |
| Average Volume (20 Days) | 29,365 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:ZYUS had revenue of CAD 481,000 and -34.43 million in losses. Loss per share was -0.47.
| Revenue | 481,000 |
| Gross Profit | -957,000 |
| Operating Income | -16.04M |
| Pretax Income | -36.50M |
| Net Income | -34.43M |
| EBITDA | -13.56M |
| EBIT | -16.04M |
| Loss Per Share | -0.47 |
Balance Sheet
The company has 663,000 in cash and 12.41 million in debt, giving a net cash position of -11.75 million or -0.15 per share.
| Cash & Cash Equivalents | 663,000 |
| Total Debt | 12.41M |
| Net Cash | -11.75M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | -7.47M |
| Book Value Per Share | -0.10 |
| Working Capital | -10.46M |
Cash Flow
In the last 12 months, operating cash flow was -9.78 million and capital expenditures -12,000, giving a free cash flow of -9.80 million.
| Operating Cash Flow | -9.78M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | -9.80M |
| FCF Per Share | -0.13 |
Margins
| Gross Margin | -198.96% |
| Operating Margin | -3,334.51% |
| Pretax Margin | -7,587.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:ZYUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.41% |
| Shareholder Yield | n/a |
| Earnings Yield | -57.74% |
| FCF Yield | -16.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |